Sai Parenteral's

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
541.50
-8.9 (-1.62%)
BSENSE

Aug 18, 04:01 PM

BSE+NSE Vol: 63.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Net Sales
381.00
163.11
153.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
381.00
163.11
153.76
Raw Material Cost
238.11
96.53
95.31
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
4.11
-2.68
-0.37
Employee Cost
29.28
13.09
12.64
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
70.80
16.79
14.52
Total Expenditure (Excl Depreciation)
342.30
123.73
122.10
Operating Profit (PBDIT) excl Other Income
38.70
39.38
31.66
Other Income
8.52
0.64
1.42
Operating Profit (PBDIT)
47.22
40.02
33.08
Interest
18.44
11.91
11.11
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
28.78
28.11
21.97
Depreciation
16.85
8.20
9.42
Profit Before Tax
11.93
19.91
12.56
Tax
-2.33
5.48
4.14
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.26
14.43
8.42
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
14.26
14.43
8.42
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.26
14.43
8.42
Equity Capital
22.09
13.31
13.25
Face Value
5.0
100.0
100.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.23
108.41
31.77
Diluted Earnings per share
4.36
108.4
31.75
Operating Profit Margin (Excl OI)
10.16%
24.14%
20.59%
Gross Profit Margin
7.55%
17.23%
14.29%
PAT Margin
3.74%
8.85%
5.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 133.58% vs 6.08% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -1.18% vs 71.38% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -1.73% vs 24.38% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 54.83% vs 7.20% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Sai Parenteral's With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
381.00
1,368.98
-987.98
-72.17%
Other Operating Income
0.00
0.00
0.00
Total Operating income
381.00
1,368.98
-987.98
-72.17%
Raw Material Cost
238.11
672.77
-434.66
-64.61%
Purchase of Finished goods
0.00
3.49
-3.49
-100.00%
(Increase) / Decrease In Stocks
4.11
8.25
-4.14
-50.18%
Employee Cost
29.28
219.20
-189.92
-86.64%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
70.80
278.52
-207.72
-74.58%
Total Expenditure (Excl Depreciation)
342.30
1,182.23
-839.93
-71.05%
Operating Profit (PBDIT) excl Other Income
38.70
186.75
-148.05
-79.28%
Other Income
8.52
6.16
2.36
38.31%
Operating Profit (PBDIT)
47.22
192.91
-145.69
-75.52%
Interest
18.44
94.75
-76.31
-80.54%
Exceptional Items
0.00
-5.89
5.89
100.00%
Gross Profit (PBDT)
28.78
92.27
-63.49
-68.81%
Depreciation
16.85
99.68
-82.83
-83.10%
Profit Before Tax
11.93
-7.41
19.34
261.00%
Tax
-2.33
0.00
-2.33
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.26
-7.41
21.67
292.44%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
14.26
-7.41
21.67
292.44%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.26
-7.41
21.67
292.44%
Equity Capital
22.09
44.51
-22.42
-50.37%
Face Value
5.00
10.00
0.00
Reserves
0.00
1,208.37
-1,208.37
-100.00%
Earnings per share (EPS)
3.23
-1.66
4.89
294.58%
Diluted Earnings per share
4.36
-1.68
6.04
359.52%
Operating Profit Margin (Excl OI)
10.16%
13.64%
0.00
-3.48%
Gross Profit Margin
7.55%
6.74%
0.00
0.81%
PAT Margin
3.74%
-0.54%
0.00
4.28%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 381.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 133.58% vs 6.08% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 14.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -1.18% vs 71.38% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.70 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -1.73% vs 24.38% in Mar 2025

Annual - Interest
Interest 18.44 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 54.83% vs 7.20% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.16%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025